Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

A novel protein, RTN-xS, interacts with both Bcl-xL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity

Abstract

Bcl-2 and Bcl-xL serve as critical inhibitors of apoptosis triggered by a broad range of stimuli, mainly acting on the mitochondria. We identified two members of the reticulon (RTN) family as Bcl-xL binding proteins, i.e., NSP-C (RTN1-C) and a new family member, RTN-xS, both of which did not belong to the Bcl-2 family and were predominantly localized on the endoplasmic reticulum (ER). RTN-xS interacted with both Bcl-xL and Bcl-2, increased the localization of Bcl-xL and Bcl-2 on the ER, and reduced the anti-apoptotic activity of Bcl-xL and Bcl-2. On the other hand, NSP-C interacted only with Bcl-xL, affected the localization of Bcl-xL, and reduced Bcl-xL activity, but had no effect on Bcl-2. These results suggest that RTN family proteins can modulate the anti-apoptotic activity of Bcl-xL and Bcl-2 by binding with them and can change their localization to the ER.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

Abbreviations

ER:

endoplasmic reticulum

mAb:

monoclonal antibody

pAb:

polyclonal antibody

TM:

tunicamycin

STS:

staurosporine

VDAC:

voltage-dependent anion channel

References

  • Adams JM and Cory S. . 1998 Science 281: 1322–1326.

  • Akao Y, Otsuki Y, Kataoka S, Ito Y and Tsujimoto Y. . 1994 Cancer Res. 54: 2468–2471.

  • Arends MJ and Wyllie AH. . 1991 Int. Rev. Exp. Pathol. 32: 223–254.

  • Baffy G, Miyashita T, Williamson JR and Reed JC. . 1993 J. Biol. Chem. 268: 6511–6519.

  • Chen DF, Schneider GE, Martinou JC and Tonegawa S. . (1997). Nature 385: 434–439.

  • Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F and Schwab ME. . 2000 Nature 403: 434–439.

  • Gonzalez GM, Perez BR, Ding L, Duan L, Boise LH, Thompson CB and Nunez G. . 1994 Development 120: 3033–3042.

  • GrandPre T, Nakamura F, Vartanian T and Strittmatter SM. . 2000 Nature 403: 439–444.

  • Green DR and Reed JC. . 1998 Science 281: 1309–1312.

  • Hausmann G, O'Reilly LA, van Driel R, Beaumont JG, Strasser A, Adams JM and Huang DC. . 2000 J. Cell Biol,. 149: 623–634.

  • He H, Lam M, McCormick TS and Distelhorst CW. . 1997 J. Cell Biol. 138: 1219–1228.

  • Hsu YT, Wolter KG and Youle RJ. . 1997 Proc. Natl. Acad. Sci. USA 94: 3668–3672.

  • Hu Y, Benedict MA, Wu D, Inohara N and Nunez G. . 1998 Proc. Natl. Acad. Sci. USA 95: 4386–4391.1.

  • Kerr JF, Wyllie AH and Currie AR. . 1972 Br. J. Cancer. 26: 239–257.

  • Iwahashi H, Eguchi Y, Yasuhara N, Hanafusa T, Matsuzawa Y and Tsujimoto Y. . 1997 Nature 390: 413–417.

  • Jia L, Macey MG, Yin Y, Newland AC and Kelsey SM. . 1999 Blood 93: 2353–2359.

  • Kaufman RJ. . 1999 Genes Dev. 13: 1211–1233.

  • Kerr JF, Wyllie AH and Currie AR. . 1972 Br. J. Cancer 26: 239–257.

  • Kluck RM, Bossy-Wetzel E, Green DR and Newmeyer DD. . 1997 Science 275: 1132–1136.

  • Krajewski S, Tanaka S, Takayama S, Schibler MJ, Fenton W and Reed JC. . 1993 Cancer Res. 53: 4701–4714.

  • Kuo TH, Kim HR, Zhu L, Yu Y, Lin HM and Tsang W. . 1998 Oncogene 17: 1903–1910.

  • Lam M, Dubyak G, Chen L, Nunez G, Miesfeld RL and Distelhorst CW. . 1994 Proc. Natl. Acad. Sci. USA 91: 6569–6573.

  • Lee JH, Takahashi T, Yasuhara N, Inazawa J, Kamada S and Tsujimoto Y. . 1999 Oncogene 18: 6183–6190.

  • Li P, Nijhawan D, Budihardjo I, Srinivasula SM, Ahmad M, Alnemri ES and Wang X. . 1997 Cell 91: 479–489.

  • Liu X, Kim CN, Yang J, Jemmerson R and Wang X. . 1996 Cell 86: 147–157.

  • Marzo I, Brenner C, Zamzami N, Jurgensmeier JM, Susin SA, Vieira HL, Prevost MC, Xie Z, Matsuyama S, Reed JC and Kroemer G. . 1998 Science 281: 2027–2031.

  • Moreira EF, Jaworski CJ and Rodriguez IR. . 1999 Genomics 58: 73–81.

  • Nagase T, Ishikawa K, Suyama M, Kikuno R, Hirosawa M, Miyajima N, Tanaka A, Kotani H, Nomura N and Ohara O. . 1998 DNA Res. 5: 355–364.

  • Nakagawa T, Zhu H, Morishima N, Li E, Xu J, Yankner BA and Yuan J. . 2000 Nature 403: 98–103.

  • Narita M, Shimizu S, Ito T, Chittenden T, Lutz RJ, Matsuda H and Tsujimoto Y. . 1998 Proc. Natl. Acad. Sci. USA 95: 14681–14686.

  • Ng FW, Nguyen M, Kwan T, Branton PE, Nicholson DW, Cromlish JA and Shore GC. . 1997 J. Cell Biol. 139: 327–338.

  • Oh YJ, Swarzenski BC and O'Malley KL. . 1996 Neurosci. Lett. 202: 161–164.

  • Pan G, O'Rourke K and Dixit VM. . 1998 J. Biol. Chem. 273: 5841–5845.

  • Roebroek AJ, van de Velde HJ, Van Bokhoven A, Broers JL, Ramaekers FC and Van de Ven WJ. . 1993 J. Biol. Chem. 268: 13439–13447.

  • Roebroek AJ, Contreras B, Pauli IG and Van de Ven WJ. . 1998 Genomics 51: 98–106.

  • Salvesen GS and Dixit VM. . 1997 Cell 91: 443–446.

  • Sato N, Hotta K, Waguri S, Nitatori T, Tohyama K, Tsujimoto Y and Uchiyama YJ. . 1994 J. Neurobiol. 25: 1227–1234.

  • Senden NH, Timmer ED, Boers JE, van de Velde HJ, Roebroek AJ, Van de Ven WJ, Broers JL and Ramaekers FC. . 1996 Eur. J. Cell Biol. 69: 197–213.

  • Shimizu S, Narita M and Tsujimoto Y. . 1999 Nature 399: 483–487.

  • Takayama S, Sato T, Krajewski S, Kochel K, Irie S, Millan JA and Reed JC. . 1995 Cell 80: 279–284.

  • Thornberry NA and Lazebnik Y. . 1998 Science 281: 1312–1316.

  • Tsujimoto Y. . 1998 Genes Cells. 3: 697–707.

  • Tsujimoto Y and Shimizu S. . 2000 FEBS Lett. 466: 6–10.

  • Yang J, Liu J, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP and Wang X. . 1997 Science 275: 1129–1132.

  • Zamzami N, Susin SA, Marchetti P, Hirsch T, Gomez-Monterrey I, Castedo M and Kroemer G. . 1996 J. Exp. Med. 183: 1533–1544.

  • Zha J, Harada H, Yang E, Jockel J and Korsmeyer SJ. . 1996 Cell 87: 619–628.

  • Zhu W, Cowie A, Wasfy GW, Penn LZ, Leber B and Andrews DW. . 1996 EMBO J. 15: 4130–4141.

  • Zou H, Henzel WJ, Liu X, Lutschg A and Wang X. . 1997 Cell 90: 405–413.

Download references

Acknowledgements

We thank Dr Kudo for providing anti-presenilin-1 antibody. We also thank Mr Kawate and Dr Kashiwagi for help with the immunocytochemical studies. This work was supported in part by Grants-in-Aid for Scientific Research on Priority Areas and for COE Research from the Japanese Ministry of Education, Science, Sport and Culture.

The nucleotide sequences of the RTN-xL and RTN-xS have been submitted to the DDBJ/EMBL/GenBank (Accession No. AB040462 and AB040463, respectively).

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Tagami, S., Eguchi, Y., Kinoshita, M. et al. A novel protein, RTN-xS, interacts with both Bcl-xL and Bcl-2 on endoplasmic reticulum and reduces their anti-apoptotic activity. Oncogene 19, 5736–5746 (2000). https://doi.org/10.1038/sj.onc.1203948

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1203948

Keywords

This article is cited by

Search

Quick links